Compound Summary
Compound Information
Brompheniramine maleate
Compound Name: | Brompheniramine maleate |
Compound CID: | 5281067 |
Synonyms: | Brompheniramine maleate 980-71-2 Brompheniramine hydrogen maleate Rolabromophen Dimotane More... |
Iupac Name: | 3-(4-bromophenyl)-N,N-dimethyl-3-pyridin-2-ylpropan-1-amine;(Z)-but-2-enedioic acid |
InChI: | InChI=1S/C16H19BrN2.C4H4O4/c1-19(2)12-10-15(16-5-3-4-11-18-16)13-6-8-14(17)9-7-13;5-3(6)1-2-4(7)8/h3-9,11,15H,10,12H2,1-2H3;1-2H,(H,5,6)(H,7,8)/b;2-1- |
InChIKey: | SRGKFVAASLQVBO-BTJKTKAUSA-N |
Canonical Smiles: | CN(C)CCC(C1=CC=C(C=C1)Br)C2=CC=CC=N2.C(=CC(=O)O)C(=O)O |
Isomeric Smiles: | CN(C)CCC(C1=CC=C(C=C1)Br)C2=CC=CC=N2.C(=C\C(=O)O)\C(=O)O |
Molecular Weight: | 435.3 |
Molecular Formula: | C20H23BrN2O4 |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
Brompheniramine maleate
Molecular Weight: | 435.3 |
Molecular Formula: | C20H23BrN2O4 |
Hydrogen Bond Donor Count: | 2 |
Hydrogen Bond Acceptor Count: | 6 |
Rotatable Bond Count: | 7 |
Heavy Atom Count: | 27 |
Complexity: | 368 |
Synonyms
Brompheniramine maleate
| Brompheniramine maleate | Brompheniramine maleate |
|---|---|
Brompheniramine maleate |
980-71-2 |
Brompheniramine hydrogen maleate |
Rolabromophen |
Dimotane |
Dimetane |
Parabromdylamine maleate |
Veltane |
Dimetane-ten |
Brompheniramine (maleate) |
Lodrane |
Brompheniramine maleate USP |
Dimetapp Allergy |
MLS000028423 |
CHEBI:3184 |
(+/-)-Brompheniramine maleate |
(+/-)-Brompheniramine maleate salt |
Drauxin |
Gammistin |
Nagemid |
SMR000058417 |
Spentane |
Allent |
Ebalin |
Brompheniramine maleate (USP) |
Drixoral Syrup |
MFCD00057367 |
Dimetane Extentabs |
Bromopheniramine maleate |
SR-01000003057 |
EINECS 213-562-9 |
BROMPHENIRAMINEMALEATE |
Dimetane (TN) |
Prestwick_913 |
3-(4-bromophenyl)-N,N-dimethyl-3-(pyridin-2-yl)propan-1-amine maleate |
Brompheniramine fumarate |
3-(4-bromophenyl)-N,N-dimethyl-3-pyridin-2-ylpropan-1-amine;(Z)-but-2-enedioic acid |
Opera_ID_399 |
2-(p-Bromo-alpha-(2-(dimethylamino)ethyl)benzyl)pyridine maleate |
2-(p-Bromo-alpha-(2-(dimethylamino)ethyl)benzyl)pyridine maleate (1:1) |
(y)-Brompheniramine maleate |
(?)-Brompheniramine maleate |
2-Pyridinepropanamine, gamma-(4-bromophenyl)-N,N-dimethyl-, (+-)-, (Z)-2-butenedioate (1:1) |
2-Pyridinepropanamine, gamma-(4-bromophenyl)-N,N-dimethyl-, (Z)-butenedioate (1:1) |
SCHEMBL41913 |
MLS001148196 |
SPECTRUM1503985 |
Bioompheniramine hydrogen maleate |
CHEMBL1200961 |
DTXSID2052657 |
(A+/-)-Brompheniramine maleate |
BCPP000315 |
HMS1569O12 |
HMS1922O16 |
HMS2093O07 |
HMS2096O12 |
HMS2230I21 |
HMS2234D14 |
HMS3260J03 |
HMS3713O12 |
HMS3884J10 |
Pharmakon1600-01503985 |
HY-B0480 |
Tox21_500201 |
CCG-39068 |
NSC758652 |
s2585 |
(+-)-2-p-Bromo-alpha-2-(dimethylamino)ethylbenzylpyridine maleate (1:1) |
AKOS015855858 |
Pyridine, 2-(p-bromo-alpha-(2-(dimethylamino)ethyl)benzyl)-, maleate (1:1) |
AC-1311 |
BCP9000453 |
LP00201 |
NSC 758652 |
NSC-758652 |
2-Pyridinepropanamine, gamma-(4-bromophenyl)-N,N-dimethyl-, (+-)-, (Z)-butenedioate (1:1) |
2-Pyridinepropanamine, gamma-(4-bromophenyl)-N,N-dimethyl-, (2Z)-2-butenedioate (1:1) |
NCGC00093676-01 |
NCGC00093676-02 |
NCGC00093676-03 |
NCGC00093676-04 |
NCGC00093676-05 |
NCGC00260886-01 |
AS-14101 |
SMR000653459 |
BCP0726000240 |
EU-0100201 |
SW197031-3 |
B 2390 |
D00663 |
( inverted question mark)-Brompheniramine maleate |
SR-01000003057-2 |
SR-01000003057-4 |
SR-01000003057-5 |
SR-01000003057-8 |
W-100095 |
Q27105975 |
2- p-Bromo-a-2-(dimethylamino)ethylbenzylpyridine maleate |
2-(p-bromo-alpha-(2-dimethylaminoethyl)benzyl)pyridine maleate |
Brompheniramine Maleate 1.0 mg/ml in Methanol (as free base) |
1-(p-bromophenyl)-1-(2-pyridyl)-3-dimethylaminopropane maleate |
3-(p-bromophenyl)-3-(2-pyridyl)-N,N-dimethylpropylamine maleate |
(+/-)-Brompheniramine maleate 100 microg/mL in Acetonitrile:Methanol |
3-(4-bromophenyl)-N,N-dimethyl-3-(2-pyridinyl)-1-propanamine maleate |
Brompheniramine maleate, United States Pharmacopeia (USP) Reference Standard |
3-(4-bromophenyl)-N,N-dimethyl-3-(pyridin-2-yl)propan-1-amine (2Z)-but-2-enedioate |
Brompheniramine Maleate, Pharmaceutical Secondary Standard; Certified Reference Material |
Brompheniramine maleate solution, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material |
Experimental Data
Brompheniramine maleate
| Species | Dosage | Unit | CG Lifespan(AVG/MED days) | TG Lifespan(AVG/MED days) | Lifespan Change(AVG/MED%) | CG Lifespan(MAX days) | TG Lifespan(MAX days) | Lifespan Change(MAX%) | Significant | Strain | Gender | PubMed | Active Label |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 33 | umol/L | 4 | NS | N2 | 24134630 | Inactive |
Experimental Data Visualization
Brompheniramine maleate
Statistics Data
Brompheniramine maleate
| Species | Lifespan Change(AVG/MED%) | Lifespan Change(MAX%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | 4 | 1 | 1 |
Statistics Data Visualization
Brompheniramine maleate
